BridgeBio Pharma, Inc. (BBIO) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2018: $87.58M2019: $155.70M2020: $595.70M2021: $1.88B2022: $1.87B2023: $1.89B2024: $2.38B2025: $3.01B$3.01B
2018Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$3.01B+26.7%
2024$2.38B+25.8%
2023$1.89B+1.1%
2022$1.87B-0.6%
2021$1.88B+215.3%
2020$595.70M+282.6%
2019$155.70M+77.8%
2018$87.58M